Employee holds vial containing Sputnik V vaccine against coronavirus disease (COVID-19) made with ingredients and technology supplied by Russia to Brazilian pharmaceutical company Uniao Quimica in Guarulhos, Brazil on May 20, 2021.Amanda Perobelli | Reuters
Russia has vehemently denied new accusations that Russian spies have stolenthe Oxford-AstraZeneca vaccine "plan " and allegedly used it to create his own coup Sputnik V, the head of the Russian sovereign wealth fund calling the claims "scientific nonsense ".
There have been new reports in the UK press this week alleging that UK security UK police services have told UK ministers they have strong evidence that Russia stole the Great Britain-made vaccine plan. Bretagne and had used it to create Sputnik V.
The Sun first reported the allegations made by the UK security services although Downing Street declined to comment. This is not the first time that Russia has been accused of attempting to steal and hack Covid vaccine data, but Moscow has repeatedly denied the charges, with RDIF calling the latest report "false." and "blatant lies".
The head of the SouvThe country's erain, RDIF, echoed the sentiment on Wednesday, calling the accusations "scientific nonsense ".
"There is no merit [to these claims] and we're very clear about it, "Kirill Dmitriev told CNBC on Wednesday. "This report is complete scientific nonsense, it has no merit and frankly it is a lie.
Calling the report "nonsense from anonymous sources, " "Dmitriev said the latest accusations were part of a " smear campaign against Sputnik V because a politician doesn't like Russia and because some big pharmaceutical companies, which are afraid of Sputnik's success. V, continue to attack Sputnik V and Sputnik Light [his single-dose booster shot] from day one, so we're used to these attacks, "he told " Street Signs Europe " from CNBC. "
Dmitriev insisted that the developers behind Sputnik V wanted to be partnerss with other vaccine producers and cited a joint clinical trial taking place with AstraZeneca (to "determine if mixed doses of Covid vaccine work ), noting " we believe in a common approach to working with other vaccine producers and Sputnik V is a partner of 'other vaccines. "
What ' s next
The investment fund Russian Direct, or RDIF, is one of the world's largest sovereign wealth funds with $ 10 billion in segregated capital under management. The fund has supported the development of Russia's primary vaccine against the coronavirus, Sputnik V, which was the f first Covid vaccine in the world to be authorized - by Russia - in August 2020.
The Sputnik V vaccine has been the subject of suspicion - primarily on its clinical data and its effectiveness - and more recently, accusations about its origin and development.ent.
Interim review of phase 3 clinical trials of the vaccine, involving "20,000 participants and published in the peer-reviewed medical journal The Lancet in early February, found it to be 91.6% effective against symptomatic Covid infection -19.
Yet the vaccine has not been approved for use by pharmaceutical authorities in the US, UK and EU. The World Organization Health said she was still evaluating the vaccine but did not say if and when she could grant the emergency use list for injections.
Not to To be discouraged, Russia has developed several other Covid vaccines and has since worked on a unique "Sputnik Light " vaccine designed to be used as a booster injection. I n August, RDIF "said Sputnik Light has been " very effective against Covid in more than 320,000 subjects who have received the vaccine based on data collected as of July 30, 2021. "He has cited an efficacy rate of 93.5%.
RDIF's Dmitriev told CNBC that Russia expects the Sputnik V vaccine to be approved by the end of 2021 and that he hopes the one shot Sputnik Light can soon be used as a booster shot in conjunction with other vaccines.
"We have seen very positive signals from the 'WHO lately and they really enjoy what we are doing ... ' Sputnik Light 'may be a booster to other vaccines like AstraZeneca and Moderna to many other vaccines, so we believe in a very solution. positive with WHO starting in the fall ... we are certainly expecting an approval very soon, "he said.